NP
ELV icon

Nilsine Partners’s Elevance Health ELV Stock Holding History

Nilsine Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$398K Sell
1,030
-112
-10% -$41.5K 0.03% 326
2026
Q1 		$407K Sell
1,142
-817
-42% -$269K 0.03% 305
2025
Q4 		$687K Buy
1,959
+41
+2% +$13.9K 0.06% 244
2025
Q3 		$620K Buy
1,918
+29
+2% +$9.02K 0.06% 254
2025
Q2 		$735K Sell
1,889
-42
-2% -$16.9K 0.07% 224
2025
Q1 		$840K Buy
1,931
+93
+5% +$37.3K 0.09% 200
2024
Q4 		$678K Sell
1,838
-298
-14% -$125K 0.07% 217
2024
Q3 		$1.11M Sell
2,136
-128
-6% -$68.4K 0.14% 165
2024
Q2 		$1.23M Buy
2,264
+12
+0.5% +$6.34K 0.16% 149
2024
Q1 		$1.17M Buy
2,252
+701
+45% +$349K 0.16% 154
2023
Q4 		$731K Buy
1,551
+48
+3% +$22.2K 0.11% 193
2023
Q3 		$654K Sell
1,503
-23
-2% -$10.4K 0.1% 196
2023
Q2 		$678K Sell
1,526
-84
-5% -$38.8K 0.1% 201
2023
Q1 		$740K Buy
+1,610
New +$766K 0.12% 186

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Nilsine Partners's ELV Position: Q2 2026 in Review

Nilsine Partners reduced its Elevance Health (ELV) stake by 9.8% in Q2 2026, selling an estimated $41.5K and leaving 1,030 shares worth $398K. The position accounts for 0.03% of the portfolio, ranked #326.

Nilsine Partners first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.23M in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Nilsine Partners held 1,030 shares of Elevance Health worth $398K as of Q2 2026.
  • Nilsine Partners sold 112 Elevance Health shares in Q2 2026, an estimated $41.5K.
  • Elevance Health made up 0.03% of Nilsine Partners's portfolio in Q2 2026, its #326 holding.
  • Nilsine Partners first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
  • Nilsine Partners's Elevance Health position peaked at $1.23M in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.